Fatigue and mortality: from description to action
A partir de données portant sur 280 patients atteints d'un syndrome myélodysplasique à haut risque (âge médian : 71 ans), cette étude de cohorte prospective internationale évalue l'association entre le degré de fatigue auto-rapportée par les patients et la survie globale
Patient-reported outcomes, including quality of life and symptom reports, have contributed to cancer care and research in many ways, including improved prognostication of how long patients with cancer will live. In The Lancet Oncology, Fabio Efficace and colleagues provide some of the first evidence that patient-reported outcomes from patients with intermediate-2-risk and high-risk myelodysplastic syndromes—specifically their ratings of fatigue—are a powerful indicator for their length of survival.
The Lancet Oncology , commentaire, 2014